L3VLUP
ProSign in

BAX in the 13F filings

Baxter Intl Inc · CUSIP 071813109

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
14 Nov 2024
latest of these filings; the earliest 12 Nov 2024
Managers listing it
9
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 8 listed it in both
Shares listed
85,124,734
combined, among listed positions
Reported value
$3.2bn
combined, at the quarter end

Among the 94 comparable managers: 6 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing BAX in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

9 of 9 holders

ActionFiling
Dodge & Cox44,598,194$1.7bn0.96%Added+17,075,44913 Nov 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc14,847,352$564m0.06%Added+51,33714 Nov 2024 (the filing on sec.gov)
Harris Associates LP9,776,407$371m0.48%Trimmed-552,52714 Nov 2024 (the filing on sec.gov)
Invesco Ltd7,870,799$299m0.06%Trimmed-34,94612 Nov 2024 (the filing on sec.gov)
Artisan Partners LP4,930,097$187m0.28%Added+637,02212 Nov 2024 (the filing on sec.gov)
Neuberger Berman Group LLC1,476,516$56munder 0.1%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Holocene Advisors LP1,317,378$50m0.20%Added+1,130,31614 Nov 2024 (the filing on sec.gov)
GAMCO Investors Inc158,673$6.0m0.06%Added+1,70514 Nov 2024 (the filing on sec.gov)
Bridgewater Associates LP149,318$5.7munder 0.1%Trimmed-472,54213 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
9 in Q3 2024 to 10 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
BAX by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201325$5.0bnn.a.n.a.
Q3 201321$4.0bnn.a.n.a.
Q4 201318$2.9bnn.a.n.a.
Q1 201419$2.4bnn.a.n.a.
Q2 201422$2.6bnn.a.n.a.
Q3 201418$2.3bnn.a.n.a.
Q4 201415$2.2bnn.a.n.a.
Q1 201522$2.5bnn.a.n.a.
Q2 201521$2.8bnn.a.n.a.
Q3 201522$4.2bnn.a.n.a.
Q4 201526$5.0bnn.a.n.a.
Q1 201627$5.2bnn.a.n.a.
Q2 201623$5.4bnn.a.n.a.
Q3 201625$5.4bnn.a.n.a.
Q4 201626$5.0bnn.a.n.a.
Q1 201727$5.6bnn.a.n.a.
Q2 201725$6.6bnn.a.n.a.
Q3 201726$6.7bnn.a.n.a.
Q4 201731$7.3bnn.a.n.a.
Q1 201832$8.2bnn.a.n.a.
Q2 201829$9.5bnn.a.n.a.
Q3 201824$9.9bnn.a.n.a.
Q4 201826$7.7bnn.a.n.a.
Q1 201926$8.6bnn.a.n.a.
Q2 201923$7.8bnn.a.n.a.
Q3 201924$7.6bnn.a.n.a.
Q4 201926$7.1bnn.a.n.a.
Q1 202029$6.3bnn.a.n.a.
Q2 202029$5.7bnn.a.n.a.
Q3 202029$4.9bnn.a.n.a.
Q4 202023$6.3bnn.a.n.a.
Q1 202119$7.5bnn.a.n.a.
Q2 202127$7.0bnn.a.n.a.
Q3 202124$6.6bnn.a.n.a.
Q4 202121$6.9bnn.a.n.a.
Q1 202226$6.5bnn.a.n.a.
Q2 202219$5.3bnn.a.n.a.
Q3 202216$4.3bnn.a.n.a.
Q4 202223$3.2bnn.a.n.a.
Q1 202326$2.4bnn.a.n.a.
Q2 202324$2.7bnn.a.n.a.
Q3 202317$2.3bnn.a.n.a.
Q4 202315$2.8bn710
Q1 202415$3.1bn78
Q2 202412$2.3bn95
Q3 20249$3.2bn63
Q4 20248$2.6bn44
Q1 20259$3.3bn63
Q2 20258$2.8bn72
Q3 202511$2.0bn83
Q4 20259$2.1bn2012
Q1 20266$1.9bn1417
Q2 202610$2.6bn1512

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

BAX and LLY →BAX and JNJ →BAX and VRTX →Choose a stock to compare with BAX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own BAX, latest filings →Back to the 13F Explorer →